Related Experiment Video
Updated: Jun 6, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Diabetes & coronary heart disease: current perspectives
Mohammed K Ali1, K M Venkat Narayan, Nikhil Tandon
1Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA. mkali@emory.edu
Insights
Coronary heart disease (CHD) and diabetes are major global health threats, especially for Indian Asians. This paper clarifies complex evidence on managing cardio-metabolic risk factors in South Asia.
Area of Science:
- Cardiology
- Metabolic Diseases
- Public Health
Background:
- Coronary heart disease (CHD) is the leading global cause of mortality.
- Diabetes exacerbates health risks, particularly in the Indian Asian population.
- Evolving evidence on risk factor management presents clinical challenges.
Purpose of the Study:
- To synthesize current research on cardio-metabolic risk management.
- To provide a clear perspective on managing CHD and diabetes in South Asia.
- To address clinical dilemmas arising from new evidence.
Main Methods:
- Review of recent clinical trials on glycemic control and macrovascular risk.
- Analysis of population-based and laboratory research findings.
- Synthesis of evidence for clinical practice guidelines.
Main Results:
- Emerging evidence necessitates updated risk factor management strategies.
- Glycemic control plays a crucial role in reducing macrovascular risk.
- South Asian populations exhibit unique cardio-metabolic risk profiles.
Conclusions:
- A nuanced approach to risk factor management is essential for South Asia.
- Integrating new evidence into practice guidelines is critical for improving outcomes.
- Further research is needed to address specific population needs.
Abstract:
Coronary heart disease (CHD) is currently the leading cause of death worldwide and together with diabetes, poses a serious health threat, particularly in the Indian Asian population. Risk factor management has evolved considerably with the continued emergence of new and thought-provoking evidence. The stream of laboratory- and population-based research findings as well as unresolved controversies may pose dilemmas and conflicting impulses in most clinicians, and even in our more well-informed patients. As results of the most recent clinical trials on glycaemic control for macrovascular risk reduction are woven into concrete clinical practice guidelines, this paper seeks to sort through unwieldy evidence, keeping these findings in perspective, to deliver a clearer message for the context of South Asia and cardio-metabolic risk management.
Related Concept Videos
Coronary Artery Disease I: Introduction
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes II: Pathophysiology
Diabetes Mellitus: Introduction
Coronary Artery Disease II: Pathophysiology